AIHA and rituximab: time for Pneumocystis prophylaxis?
作者信息
Hansen Dennis Lund, Frederiksen Henrik
机构信息
Department of Hematology, Odense University Hospital, Odense, Denmark.
Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
出版信息
Blood Adv. 2025 Jan 14;9(1):229-230. doi: 10.1182/bloodadvances.2024014513.
Abstract
摘要
相似文献
1
AIHA and rituximab: time for Pneumocystis prophylaxis?自身免疫性溶血性贫血与利妥昔单抗：是时候进行肺孢子菌预防了吗？
Blood Adv. 2025 Jan 14;9(1):229-230. doi: 10.1182/bloodadvances.2024014513.
2
Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies.利妥昔单抗治疗自身免疫性溶血性贫血的疗效和安全性：21 项研究的荟萃分析。
Autoimmun Rev. 2015 Apr;14(4):304-13. doi: 10.1016/j.autrev.2014.11.014. Epub 2014 Dec 9.
3
Risk of hospitalization with infection in adults with primary AIHA treated with rituximab: a French nationwide study.接受利妥昔单抗治疗的原发性自身免疫性溶血性贫血成年患者发生感染相关住院的风险：一项法国全国性研究。
Blood Adv. 2025 Jan 14;9(1):231-238. doi: 10.1182/bloodadvances.2024013067.
4
Pneumocystis jirovecii pneumonia in HIV-uninfected, rituximab treated non-Hodgkin lymphoma patients.HIV 阴性、利妥昔单抗治疗的非霍奇金淋巴瘤患者中的肺孢子菌肺炎。
Sci Rep. 2018 May 29;8(1):8321. doi: 10.1038/s41598-018-26743-4.
5
Primary Prophylaxis for Pneumocystis jirovecii Pneumonia in Patients Receiving Rituximab.利妥昔单抗治疗患者的肺孢子菌肺炎的一级预防。
Chest. 2022 May;161(5):1201-1210. doi: 10.1016/j.chest.2021.11.007. Epub 2021 Nov 14.
6
Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.利妥昔单抗治疗自身免疫性溶血性贫血和免疫性血小板减少性紫癜：一项比利时回顾性多中心研究。
J Intern Med. 2009 Nov;266(5):484-91. doi: 10.1111/j.1365-2796.2009.02126.x. Epub 2009 Apr 27.
7
Intravascular hemolysis and multitreatment predict thrombosis in patients with autoimmune hemolytic anemia.血管内溶血和多治疗可预测自身免疫性溶血性贫血患者的血栓形成。
J Thromb Haemost. 2022 Aug;20(8):1852-1858. doi: 10.1111/jth.15757. Epub 2022 May 30.
8
Prophylaxis and Treatment of Pneumocystis jiroveci Pneumonia in Lymphoma Patients Subjected to Rituximab-Contained Therapy: A Systemic Review and Meta-Analysis.接受含利妥昔单抗治疗的淋巴瘤患者中耶氏肺孢子菌肺炎的预防与治疗：一项系统评价和荟萃分析
PLoS One. 2015 Apr 24;10(4):e0122171. doi: 10.1371/journal.pone.0122171. eCollection 2015.
9
Late-onset Pneumocystis jirovecii pneumonia post-fludarabine, cyclophosphamide and rituximab: implications for prophylaxis.氟达拉滨、环磷酰胺和利妥昔单抗治疗后继发迟发性肺囊虫肺炎：预防的意义。
Eur J Haematol. 2013 Aug;91(2):157-63. doi: 10.1111/ejh.12135. Epub 2013 Jun 15.
10
Low incidence of pneumocystis pneumonia utilizing PCR-based diagnosis in patients with B-cell lymphoma receiving rituximab-containing combination chemotherapy.利妥昔单抗联合化疗治疗 B 细胞淋巴瘤患者中基于 PCR 的诊断方法使肺孢子菌肺炎发生率降低。
Am J Hematol. 2016 Nov;91(11):1113-1117. doi: 10.1002/ajh.24499. Epub 2016 Aug 22.
本文引用的文献
1
Risk of hospitalization with infection in adults with primary AIHA treated with rituximab: a French nationwide study.接受利妥昔单抗治疗的原发性自身免疫性溶血性贫血成年患者发生感染相关住院的风险：一项法国全国性研究。
Blood Adv. 2025 Jan 14;9(1):231-238. doi: 10.1182/bloodadvances.2024013067.
2
Prophylaxis Against Pneumocystis jirovecii Pneumonia in Adults.成人耶氏肺孢子菌肺炎的预防
JAMA. 2023 Jul 11;330(2):182-183. doi: 10.1001/jama.2023.9844.
3
Survival in autoimmune hemolytic anemia remains poor, results from a nationwide cohort with 37 years of follow-up.自身免疫性溶血性贫血的生存率仍然较差，这是一项全国性队列研究随访 37 年的结果。
Eur J Haematol. 2022 Jul;109(1):10-20. doi: 10.1111/ejh.13764. Epub 2022 Mar 19.
4
Epidemiology of autoimmune hemolytic anemia: A nationwide population-based study in France.自身免疫性溶血性贫血的流行病学：法国一项基于全国人口的研究。
Am J Hematol. 2021 Aug 1;96(8):E291-E293. doi: 10.1002/ajh.26213. Epub 2021 May 22.
5
Rituximab identified as an independent risk factor for severe PJP: A case-control study.利妥昔单抗被确定为严重 PJP 的独立危险因素：一项病例对照研究。
PLoS One. 2020 Sep 11;15(9):e0239042. doi: 10.1371/journal.pone.0239042. eCollection 2020.
6
Risk Factors and Prevention of Pneumocystis jirovecii Pneumonia in Patients With Autoimmune and Inflammatory Diseases.自身免疫性和炎症性疾病患者中耶氏肺孢子菌肺炎的危险因素和预防。
Chest. 2020 Dec;158(6):2323-2332. doi: 10.1016/j.chest.2020.05.558. Epub 2020 Jun 2.
7
Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting.成人自身免疫性溶血性贫血的诊断和治疗：首次国际共识会议的建议。
Blood Rev. 2020 May;41:100648. doi: 10.1016/j.blre.2019.100648. Epub 2019 Dec 5.
8
Low-dose rituximab in autoimmune hemolytic anemia: 10 years after.低剂量利妥昔单抗治疗自身免疫性溶血性贫血：十年之后
Blood. 2019 Feb 28;133(9):996-998. doi: 10.1182/blood-2018-12-885228. Epub 2019 Jan 22.
9
Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.非HIV免疫功能低下患者肺孢子菌肺炎（PCP）的预防
Cochrane Database Syst Rev. 2014 Oct 1;2014(10):CD005590. doi: 10.1002/14651858.CD005590.pub3.
Zotero 插件